Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.35 (
matrix metalloproteinase 9
)
2,207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To explore the expression of
matrix metalloproteinase 9
(
MMP-9
), type IV collagen (Col IV) and vascular endothelial growth factor (VEGF) in adamantinomatous
craniopharyngioma
(ACP) and analyze the correlation between the level of these markers and adamantimous craniopharyngiomas recurrence. Expressions of
MMP-9
, Col IV and VEGF were tested by immunohistochemistry (IHC) in 40 cases of ACP, including 24 cases of primary group and 16 cases of recurred group. The expression level of
MMP-9
and VEGF in recurred group were significantly higher than primary group (93.7% vs. 41.7%, P < 0.05, 87.5% vs. 45.8%, P < 0.05, respectively). The expression of Col IV in the recurred group was significant different from the primary group (Z = -2.619, P < 0.05).
MMP-9
, Col IV and VEGF may be the potential specific bio-marker related to the recurrence of ACP.
...
PMID:Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma. 2181 23
